This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lohman, B L Articles by Marthas, M L Search for Related Content PubMed PubMed Citation Articles by Lohman, B L Articles by Marthas, M L

 Previous Article  |  Next Article 

J Virol. 1994 November; 68(11): 7021-7029

A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge.

Department of Medicine, University of California--Davis 95616.

ABSTRACT

Three infectious, attenuated molecular clones of simian immunodeficiency virus (SIVmac) were tested for viral and host determinants of protective immunity. The viruses differed in degree of virulence from highly attenuated to moderately attenuated to partially attenuated. Levels of immune stimulation and antiviral immunity were measured in rhesus macaques inoculated 2 years previously with these viruses. Monkeys infected with the highly attenuated or moderately attenuated viruses had minimal lymphoid hyperplasia, normal CD4/CD8 ratios, low levels of SIV-specific antibodies, and cytotoxic T-lymphocyte activity against p55gag (Gag) or gp160env (Env). Monkeys infected with the partially attenuated virus had moderate to marked lymphoid hyperplasia, normal CD4/CD8 ratios, high levels of SIV-specific antibodies, and cytotoxic T-lymphocyte activity against both Gag and Env. After pathogenic virus challenge, monkeys immunized with the partially attenuated virus had 100- to 1,000-fold-lower viral load in peripheral blood mononuclear cells and lymph node mononuclear cells than naive control animals. One of four monkeys immunized with the highly attenuated virus and two of four monkeys immunized with the moderately attenuated virus developed similarly low viral loads after challenge. These three attenuated strains of SIV induced a spectrum of antiviral immunity that was inversely associated with their degree of attenuation. Only the least attenuated virus induced resistance to challenge infection in all immunized monkeys.

This article has been cited by other articles:

• Berry, N., Stebbings, R., Ferguson, D., Ham, C., Alden, J., Brown, S., Jenkins, A., Lines, J., Duffy, L., Davis, L., Elsley, W., Page, M., Hull, R., Stott, J., Almond, N. (2008). Resistance to superinfection by a vigorously replicating, uncloned stock of simian immunodeficiency virus (SIVmac251) stimulates replication of a live attenuated virus vaccine (SIVmacC8). J. Gen. Virol. 89: 2240-2251 [Abstract] [Full Text]  
• Das, A. T., Klaver, B., Harwig, A., Vink, M., Ooms, M., Centlivre, M., Berkhout, B. (2007). Construction of a Doxycycline-Dependent Simian Immunodeficiency Virus Reveals a Nontranscriptional Function of Tat in Viral Replication. J. Virol. 81: 11159-11169 [Abstract] [Full Text]  
• Amara, R. R., Patel, K., Niedziela, G., Nigam, P., Sharma, S., Staprans, S. I., Montefiori, D. C., Chenareddi, L., Herndon, J. G., Robinson, H. L., McClure, H. M., Novembre, F. J. (2005). A Combination DNA and Attenuated Simian Immunodeficiency Virus Vaccine Strategy Provides Enhanced Protection from Simian/Human Immunodeficiency Virus-Induced Disease. J. Virol. 79: 15356-15367 [Abstract] [Full Text]  
• Stebbings, R., Berry, N., Waldmann, H., Bird, P., Hale, G., Stott, J., North, D., Hull, R., Hall, J., Lines, J., Brown, S., D'Arcy, N., Davis, L., Elsley, W., Edwards, C., Ferguson, D., Allen, J., Almond, N. (2005). CD8+ Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus. J. Virol. 79: 12264-12272 [Abstract] [Full Text]  
• North, T. W., Van Rompay, K. K. A., Higgins, J., Matthews, T. B., Wadford, D. A., Pedersen, N. C., Schinazi, R. F. (2005). Suppression of Virus Load by Highly Active Antiretroviral Therapy in Rhesus Macaques Infected with a Recombinant Simian Immunodeficiency Virus Containing Reverse Transcriptase from Human Immunodeficiency Virus Type 1. J. Virol. 79: 7349-7354 [Abstract] [Full Text]  
• Sharpe, S. A., Cope, A., Dowall, S., Berry, N., Ham, C., Heeney, J. L., Hopkins, D., Easterbrook, L., Dennis, M., Almond, N., Cranage, M. (2004). Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope. J. Gen. Virol. 85: 2591-2602 [Abstract] [Full Text]  
• Pistello, M., Matteucci, D., Bonci, F., Isola, P., Mazzetti, P., Zaccaro, L., Merico, A., Del Mauro, D., Flynn, N., Bendinelli, M. (2003). AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Protection from an Intraclade Challenge Administered Systemically or Mucosally by an Attenuated Vaccine. J. Virol. 77: 10740-10750 [Abstract] [Full Text]  
• Shacklett, B. L., Shaw, K. E. S., Adamson, L. A., Wilkens, D. T., Cox, C. A., Montefiori, D. C., Gardner, M. B., Sonigo, P., Luciw, P. A. (2002). Live, Attenuated Simian Immunodeficiency Virus SIVmac-M4, with Point Mutations in the Env Transmembrane Protein Intracytoplasmic Domain, Provides Partial Protection from Mucosal Challenge with Pathogenic SIVmac251. J. Virol. 76: 11365-11378 [Abstract] [Full Text]  
• Walther-Jallow, L., Nilsson, C., Soderlund, J., ten Haaft, P., Makitalo, B., Biberfeld, P., Bottiger, P., Heeney, J., Biberfeld, G., Thorstensson, R. (2001). Cross-protection against mucosal simian immunodeficiency virus (SIVsm) challenge in human immunodeficiency virus type 2-vaccinated cynomolgus monkeys. J. Gen. Virol. 82: 1601-1612 [Abstract] [Full Text]  
• Khatissian, E., Monceaux, V., Cumont, M.-C., Kieny, M.-P., Aubertin, A.-M., Hurtrel, B. (2001). Persistence of Pathogenic Challenge Virus in Macaques Protected by Simian Immunodeficiency Virus SIVmac{Delta}nef. J. Virol. 75: 1507-1515 [Abstract] [Full Text]  
• Verhoef, K., Marzio, G., Hillen, W., Bujard, H., Berkhout, B. (2001). Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat. J. Virol. 75: 979-987 [Abstract] [Full Text]  
• Fultz, P. N., Vance, P. J., Endres, M. J., Tao, B., Dvorin, J. D., Davis, I. C., Lifson, J. D., Montefiori, D. C., Marsh, M., Malim, M. H., Hoxie, J. A. (2001). In Vivo Attenuation of Simian Immunodeficiency Virus by Disruption of a Tyrosine-Dependent Sorting Signal in the Envelope Glycoprotein Cytoplasmic Tail. J. Virol. 75: 278-291 [Abstract] [Full Text]  
• Otten, R. A., Smith, D. K., Adams, D. R., Pullium, J. K., Jackson, E., Kim, C. N., Jaffe, H., Janssen, R., Butera, S., Folks, T. M. (2000). Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2). J. Virol. 74: 9771-9775 [Abstract] [Full Text]  
• Shacklett, B. L., Weber, C. J., Shaw, K. E. S., Keddie, E. M., Gardner, M. B., Sonigo, P., Luciw, P. A. (2000). The Intracytoplasmic Domain of the Env Transmembrane Protein Is a Locus for Attenuation of Simian Immunodeficiency Virus SIVmac in Rhesus Macaques. J. Virol. 74: 5836-5844 [Abstract] [Full Text]  
• Gundlach, B. R., Lewis, M. G., Sopper, S., Schnell, T., Sodroski, J., Stahl-Hennig, C., Überla, K. (2000). Evidence for Recombination of Live, Attenuated Immunodeficiency Virus Vaccine with Challenge Virus to a More Virulent Strain. J. Virol. 74: 3537-3542 [Abstract] [Full Text]  
• Rosenwirth, B., ten Haaft, P., Bogers, W. M. J. M., Nieuwenhuis, I. G., Niphuis, H., Kuhn, E.-M., Bischofberger, N., Heeney, J. L., Überla, K. (2000). Antiretroviral Therapy during Primary Immunodeficiency Virus Infection Can Induce Persistent Suppression of Virus Load and Protection from Heterologous Challenge in Rhesus Macaques. J. Virol. 74: 1704-1711 [Abstract] [Full Text]  
• Crotty, S., Lohman, B. L., Lu, F. X.-S., Tang, S., Miller, C. J., Andino, R. (1999). Mucosal Immunization of Cynomolgus Macaques with Two Serotypes of Live Poliovirus Vectors Expressing Simian Immunodeficiency Virus Antigens: Stimulation of Humoral, Mucosal, and Cellular Immunity. J. Virol. 73: 9485-9495 [Abstract] [Full Text]  
• Metzner, K. J., Jin, X., Lee, F. V., Gettie, A., Bauer, D. E., Di Mascio, M., Perelson, A. S., Marx, P. A., Ho, D. D., Kostrikis, L. G., Connor, R. I. (1999). Effects of In Vivo CD8+ T Cell Depletion on Virus Replication in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine. J. Exp. Med. 191: 1921-1932 [Abstract] [Full Text]  
• Johnson, R. P., Lifson, J. D., Czajak, S. C., Cole, K. S., Manson, K. H., Glickman, R., Yang, J., Montefiori, D. C., Montelaro, R., Wyand, M. S., Desrosiers, R. C. (1999). Highly Attenuated Vaccine Strains of Simian Immunodeficiency Virus Protect against Vaginal Challenge: Inverse Relationship of Degree of Protection with Level of Attenuation. J. Virol. 73: 4952-4961 [Abstract] [Full Text]  
• Sodora, D. L., Sheridan, K. E., Marx, P. A., Connor, R. I. (1999). Immunization with a Live, Attenuated Simian Immunodeficiency Virus Vaccine Leads to Restriction of Viral Diversity in Rhesus Macaques Not Protected from Pathogenic Challenge. J. Virol. 73: 4443-4446 [Abstract] [Full Text]  
• Berkhout, B., Verhoef, K., van Wamel, J. L. B., Back, N. K. T. (1999). Genetic Instability of Live, Attenuated Human Immunodeficiency Virus Type 1 Vaccine Strains. J. Virol. 73: 1138-1145 [Abstract] [Full Text]  
• Dyer, W. B., Ogg, G. S., Demoitie, M.-A., Jin, X., Geczy, A. F., Rowland-Jones, S. L., McMichael, A. J., Nixon, D. F., Sullivan, J. S. (1999). Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1. J. Virol. 73: 436-443 [Abstract] [Full Text]  
• McChesney, M. B., Collins, J. R., Lu, D., Lu, X., Torten, J., Ashley, R. L., Cloyd, M. W., Miller, C. J. (1998). Occult Systemic Infection and Persistent Simian Immunodeficiency Virus (SIV)-Specific CD4+-T-Cell Proliferative Responses in Rhesus Macaques That Were Transiently Viremic after Intravaginal Inoculation of SIV. J. Virol. 72: 10029-10035 [Abstract] [Full Text]  
• Imaoka, K., Miller, C. J., Kubota, M., McChesney, M. B., Lohman, B., Yamamoto, M., Fujihashi, K., Someya, K., Honda, M., McGhee, J. R., Kiyono, H. (1998). Nasal Immunization of Nonhuman Primates with Simian Immunodeficiency Virus p55gag and Cholera Toxin Adjuvant Induces Th1/Th2 Help for Virus-Specific Immune Responses in Reproductive Tissues. J. Immunol. 161: 5952-5958 [Abstract] [Full Text]  
• Gundlach, B. R., Reiprich, S., Sopper, S., Means, R. E., Dittmer, U., Matz-Rensing, K., Stahl-Hennig, C., Uberla, K. (1998). Env-Independent Protection Induced by Live, Attenuated Simian Immunodeficiency Virus Vaccines. J. Virol. 72: 7846-7851 [Abstract] [Full Text]  
• Cole, K. S., Murphey-Corb, M., Narayan, O., Joag, S. V., Shaw, G. M., Montelaro, R. C. (1998). Common Themes of Antibody Maturation to Simian Immunodeficiency Virus, Simian-Human Immunodeficiency Virus, and Human Immunodeficiency Virus Type 1 Infections. J. Virol. 72: 7852-7859 [Abstract] [Full Text]  
• Connor, R. I., Montefiori, D. C., Binley, J. M., Moore, J. P., Bonhoeffer, S., Gettie, A., Fenamore, E. A., Sheridan, K. E., Ho, D. D., Dailey, P. J., Marx, P. A. (1998). Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine. J. Virol. 72: 7501-7509 [Abstract] [Full Text]  
• Harmache, A., Vitu, C., Guiguen, F., Russo, P., Bertoni, G., Pepin, M., Vigne, R., Suzan, M. (1998). Priming with tat-Deleted Caprine Arthritis Encephalitis Virus (CAEV) Proviral DNA or Live Virus Protects Goats from Challenge with Pathogenic CAEV. J. Virol. 72: 6796-6804 [Abstract] [Full Text]  
• Langlois, A. J., Desrosiers, R. C., Lewis, M. G., KewalRamani, V. N., Littman, D. R., Zhou, J. Y., Manson, K., Wyand, M. S., Bolognesi, D. P., Montefiori, D. C. (1998). Neutralizing Antibodies in Sera from Macaques Immunized with Attenuated Simian Immunodeficiency Virus. J. Virol. 72: 6950-6955 [Abstract] [Full Text]  
• Smith, A. D., Geisler, S. C., Chen, A. A., Resnick, D. A., Roy, B. M., Lewi, P. J., Arnold, E., Arnold, G. F. (1998). Human Rhinovirus Type 14:Human Immunodeficiency Virus Type 1 (HIV-1) V3 Loop Chimeras from a Combinatorial Library Induce Potent Neutralizing Antibody Responses against HIV-1. J. Virol. 72: 651-659 [Abstract] [Full Text]  
• Marzio, G., Verhoef, K., Vink, M., Berkhout, B. (2001). In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc. Natl. Acad. Sci. USA 98: 6342-6347 [Abstract] [Full Text]